Your browser doesn't support javascript.
loading
LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212.
Zhang, Zhe; Nong, Li; Chen, Meng-Lei; Gu, Xiao-Li; Zhao, Wei-Wei; Liu, Ming-Hui; Cheng, Wen-Wu.
Afiliación
  • Zhang Z; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Nong L; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Chen ML; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Gu XL; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhao WW; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Liu MH; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Cheng WW; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Cancer Biother Radiopharm ; 37(2): 119-124, 2022 Mar.
Article en En | MEDLINE | ID: mdl-32598181
ABSTRACT
LncRNA ELF3-AS1 has been characterized as an oncogenic lncRNA in bladder cancer and oral cancer, whereas its role in non-small cell lung cancer (NSCLC) is unknown. In this study, the authors observed that ELF3-AS1 was upregulated in NSCLC tissues in comparison with that in paired nontumor tissues collected from 68 NSCLC patients. High expression levels of ELF3-AS1 predicted the poor survival of NSCLC patients. Expression levels of miR-212 were inversely and significantly correlated with the expression levels of ELF3-AS1 across NSCLC tissue samples. In NSCLC cells, overexpression of ELF3-AS1 led to downregulated miR-212 and increased methylation of miR-212 gene. In addition, overexpression of ELF3-AS1 inhibited the role of miR-212 in suppressing cancer cell invasion and migration. Therefore, ELF3-AS1 is upregulated in NSCLC and promotes cancer cell invasion and migration by downregulating miR-212 through methylation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / ARN Largo no Codificante / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Biother Radiopharm Asunto de la revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / ARN Largo no Codificante / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Biother Radiopharm Asunto de la revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China